Document is current
Any future updates will be listed below
-
Authors
Onishi-Seebacher, M.
Erikson, G.
Sawitzki, Z.
Ryan, D.
Greve, G.
Lübbert, M.
Jenuwein, T. http://orcid.org/0000-0002-0470-0421
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC 992)
Max-Planck-Gesellschaft
Deutsche Forschungsgemeinschaft (CRC 992-C04, FOR 2674-A05)
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE)
- License Information
-
More Information
Article History
Received: 2 July 2020
Accepted: 7 June 2021
First Online: 26 June 2021
Declaration
:
: The study was approved by the Ethik-Kommission Universitätsklinikum Freiburg under permit number 388/11 (2011): “Registry study on biological disease profile and clinical outcome in Acute Myeloid Leukemia and related neoplasms”. All human subjects provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
